Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Infectious Diseases and Therapy|June 24, 2026
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C InfectionChristoph Boesecke, Kimberly Workowski, Stuart C Gordon, et al.
Journal of Hepatology|May 5, 2015
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010Robert D Allison, Xin Tong, Anne C Moorman, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2020
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherenceMark Sulkowski, Annie F Luetkemeyer, David L Wyles, et al.
Journal of Viral Hepatitis|July 7, 2023
Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis CMei Lu, Reena Salgia, Jia Li, et al.
Journal of Racial and Ethnic Health Disparities|November 24, 2020
African Americans Demonstrate Significantly Lower Serum Alanine Aminotransferase Compared to Non-African AmericansAdarsh Varma, Sheri Trudeau, Yueren Zhou, et al.
Alimentary Pharmacology & Therapeutics|February 9, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United StatesW Ray Kim, Laura E Telep, Belinda Jump, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 13, 2018
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis CZobair M Younossi, Maria Stepanova, Rajender Reddy, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infectionJohn G McHutchison, Gregory T Everson, Stuart C Gordon, et al.
BMJ Open Gastroenterology|March 27, 2026
Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort studyKimberly A Brown, Stuart C Gordon, Yichu Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2025
Antiviral treatment Reduces Risk of Development of Lung Cancer and non-Hodgkin Lymphoma in Patients with Chronic Hepatitis CMeng Hua Tao, Trueman Wu, Stuart C Gordon, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Infectious Diseases and Therapy|June 24, 2026
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C InfectionChristoph Boesecke, Kimberly Workowski, Stuart C Gordon, et al.
Journal of Hepatology|May 5, 2015
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010Robert D Allison, Xin Tong, Anne C Moorman, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2020
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherenceMark Sulkowski, Annie F Luetkemeyer, David L Wyles, et al.
Journal of Viral Hepatitis|July 7, 2023
Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis CMei Lu, Reena Salgia, Jia Li, et al.
Journal of Racial and Ethnic Health Disparities|November 24, 2020
African Americans Demonstrate Significantly Lower Serum Alanine Aminotransferase Compared to Non-African AmericansAdarsh Varma, Sheri Trudeau, Yueren Zhou, et al.
Alimentary Pharmacology & Therapeutics|February 9, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United StatesW Ray Kim, Laura E Telep, Belinda Jump, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 13, 2018
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis CZobair M Younossi, Maria Stepanova, Rajender Reddy, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infectionJohn G McHutchison, Gregory T Everson, Stuart C Gordon, et al.
BMJ Open Gastroenterology|March 27, 2026
Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort studyKimberly A Brown, Stuart C Gordon, Yichu Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2025
Antiviral treatment Reduces Risk of Development of Lung Cancer and non-Hodgkin Lymphoma in Patients with Chronic Hepatitis CMeng Hua Tao, Trueman Wu, Stuart C Gordon, et al.
Pageof 22